These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Mechanisms of platelet-activating factor-induced lipid body formation: requisite roles for 5-lipoxygenase and de novo protein synthesis in the compartmentalization of neutrophil lipids. Bozza PT; Payne JL; Goulet JL; Weller PF J Exp Med; 1996 Apr; 183(4):1515-25. PubMed ID: 8666909 [TBL] [Abstract][Full Text] [Related]
23. 5-Lipoxygenase products modulate the activity of the 85-kDa phospholipase A2 in human neutrophils. Wijkander J; O'Flaherty JT; Nixon AB; Wykle RL J Biol Chem; 1995 Nov; 270(44):26543-9. PubMed ID: 7592874 [TBL] [Abstract][Full Text] [Related]
24. Calcium regulation of the human PMN cytosolic 15-lipoxygenase. Nichols RC; Vanderhoek JY Biochim Biophys Acta; 1991 Aug; 1085(1):77-81. PubMed ID: 1892881 [TBL] [Abstract][Full Text] [Related]
25. BRP-187: A potent inhibitor of leukotriene biosynthesis that acts through impeding the dynamic 5-lipoxygenase/5-lipoxygenase-activating protein (FLAP) complex assembly. Garscha U; Voelker S; Pace S; Gerstmeier J; Emini B; Liening S; Rossi A; Weinigel C; Rummler S; Schubert US; Scriba GK; Çelikoğlu E; Çalışkan B; Banoglu E; Sautebin L; Werz O Biochem Pharmacol; 2016 Nov; 119():17-26. PubMed ID: 27592027 [TBL] [Abstract][Full Text] [Related]
26. 5-Hydroxyeicosanoids selectively stimulate the human neutrophil 15-lipoxygenase to use endogenous substrate. Nichols RC; Vanderhoek JY J Exp Med; 1990 Feb; 171(2):367-75. PubMed ID: 2154526 [TBL] [Abstract][Full Text] [Related]
27. Capacity for repeatable leukotriene generation after transient stimulation of mast cells and macrophages. Brock TG; McNish RW; Peters-Golden M Biochem J; 1998 Feb; 329 ( Pt 3)(Pt 3):519-25. PubMed ID: 9445378 [TBL] [Abstract][Full Text] [Related]
28. Intrinsic 5-lipoxygenase activity is required for neutrophil responsivity. Guidot DM; Repine MJ; Westcott JY; Repine JE Proc Natl Acad Sci U S A; 1994 Aug; 91(17):8156-9. PubMed ID: 8058773 [TBL] [Abstract][Full Text] [Related]
29. The suppression of 5-lipoxygenation of arachidonic acid in human polymorphonuclear leucocytes by the 15-lipoxygenase product (15S)-hydroxy-(5Z,8Z,11Z,13E)-eicosatetraenoic acid: structure-activity relationship and mechanism of action. Petrich K; Ludwig P; Kühn H; Schewe T Biochem J; 1996 Mar; 314 ( Pt 3)(Pt 3):911-6. PubMed ID: 8615788 [TBL] [Abstract][Full Text] [Related]
31. Lipoxygenase products of arachidonic acid modulate biosynthesis of platelet-activating factor (1-O-alkyl-2-acetyl-sn-glycero-3-phosphocholine) by human neutrophils via phospholipase A2. Billah MM; Bryant RW; Siegel MI J Biol Chem; 1985 Jun; 260(11):6899-906. PubMed ID: 3922982 [TBL] [Abstract][Full Text] [Related]
32. A rat air pouch model for evaluating the efficacy and selectivity of 5-lipoxygenase inhibitors. Zweifel BS; Hardy MM; Anderson GD; Dufield DR; Pufahl RA; Masferrer JL Eur J Pharmacol; 2008 Apr; 584(1):166-74. PubMed ID: 18295198 [TBL] [Abstract][Full Text] [Related]
33. 5(S),15(S)-dihydroxyeicosatetraenoic acid and lipoxin generation in human polymorphonuclear cells: dual specificity of 5-lipoxygenase towards endogenous and exogenous precursors. Chavis C; Vachier I; Chanez P; Bousquet J; Godard P J Exp Med; 1996 Apr; 183(4):1633-43. PubMed ID: 8666921 [TBL] [Abstract][Full Text] [Related]
34. 5-lipoxygenase-dependent biosynthesis of novel 20:4 n-3 metabolites with anti-inflammatory activity. Gagnon KJ; Lefort N; Poirier SJ; Barnett DA; Surette ME Prostaglandins Leukot Essent Fatty Acids; 2018 Nov; 138():38-44. PubMed ID: 30392579 [TBL] [Abstract][Full Text] [Related]
35. BIRM 270: a novel inhibitor of arachidonate release that blocks leukotriene B4 and platelet-activating factor biosynthesis in human neutrophils. Farina PR; Graham AG; Hoffman AF; Watrous JM; Borgeat P; Nadeau M; Hansen G; Dinallo RM; Adams J; Miao CK J Pharmacol Exp Ther; 1994 Dec; 271(3):1418-26. PubMed ID: 7996454 [TBL] [Abstract][Full Text] [Related]
36. Platelets may inhibit leucotriene biosynthesis by human neutrophils at the integrin level. Chabannes B; Moliere P; Merhi-Soussi F; Poubelle PE; Lagarde M Br J Haematol; 2003 Apr; 121(2):341-8. PubMed ID: 12694258 [TBL] [Abstract][Full Text] [Related]
37. Properties of LTA4 synthase in human neutrophil preparations. Hill E; MacMillan D; Sala A; Henson PM; Murphy RC Adv Prostaglandin Thromboxane Leukot Res; 1995; 23():155-7. PubMed ID: 7732823 [No Abstract] [Full Text] [Related]
38. Modulation of rat polymorphonuclear leukocyte 5-lipoxygenase activity by 5-HPETE and NADH-dependent flavin inhibition. Riendeau D; Leblanc Y Biochem Biophys Res Commun; 1986 Dec; 141(2):534-40. PubMed ID: 3099790 [TBL] [Abstract][Full Text] [Related]
39. Enhancement of platelet-activating factor-induced leukotriene synthesis in neutrophils by granulocyte-macrophage colony-stimulating factor (GM-CSF): studies on the mechanism of action of GM-CSF. McColl SR; Krump E; McDonald PP; Braquet M; Naccache PH; Borgeat P J Lipid Mediat; 1990; 2 Suppl():S119-27. PubMed ID: 1966811 [TBL] [Abstract][Full Text] [Related]
40. Inhibition of mitogen-activated protein kinase kinase blocks activation and redistribution of 5-lipoxygenase in HL-60 cells. Lepley RA; Fitzpatrick FA Arch Biochem Biophys; 1996 Jul; 331(1):141-4. PubMed ID: 8660693 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]